Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rejuve.AI is a private digital health and longevity company building a decentralized platform that combines artificial intelligence, blockchain infrastructure, and real-world health data to generate personalized longevity insights. Its main commercial product is the Rejuve Longevity App, which aggregates user health information, estimates biological age, provides health and aging-related scores, and rewards participation with RJV tokens. The company is also developing an AI-enabled research ecosystem centered on its International Longevity Research Database and models such as RejuveAge-Q, LinAge2, and Bayes Expert to support biomarker discovery and individualized longevity strategies. Rejuve.AI appears to operate primarily as a health-tech and research platform rather than as a traditional therapeutics developer with named clinical drug assets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rejuve.AI.